Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancer
{{output}}
Background: Anamorelin, a drug to treat cancer cachexia, binds to ghrelin receptors and improves body weight and appetite. In clinical trials in Japan, patients experienced a 10.7% frequency of stimulant conduction system depress... ...
